Paracetamol formulations containing sodium have been linked to an increased risk of cardiovascular disease and mortality in people with and without hypertension, in a population-based cohort study.
Excessive sodium intake was a major public health concern globally, researchers wrote in the European Heart Journal, noting sodium was widely used to help medications dissolve.
Previous studies had found high sodium intake was linked with increased risks of cardiovascular disease (CVD) and all-cause mortality among those with hypertension, but the findings in people without hypertension had been unclear.
Using an electronic medical record database with records of approximately 17 million patients cared for by GPs in the UK, researchers compared the risks of incident CVD and all-cause mortality over a year of follow-up among people prescribed sodium-containing paracetamol compared with those prescribed paracetamol without sodium in a group of people with hypertension and a cohort without the condition.
Among those with hypertension, who had a mean age of 73.4 years, researchers found 122 incident CVDs (myocardial infarction, stroke, and heart failure) among 4532 initiators of sodium-containing paracetamol (1 year risk: 5.6%) compared with 3051 among 146 866 non-sodium-containing paracetamol initiators (1-year risk: 4.6%).
Among people without hypertension, who had a mean age of 71 years, there were 105 CVDs among 5351 initiators of sodium-containing paracetamol (1-year risk: 4.4%) and 2079 among 141 948 non-sodium-containing paracetamol initiators (1-year risk: 3.7%).
‘Results of specific CVD outcomes and all-cause mortality were similar,’ the researchers wrote.
‘The risk of CVD and mortality increased as the duration of sodium-containing acetaminophen increased. Our findings were consistent in several sensitivity analyses, indicating that observed associations were robust.’
The effervescent and soluble formulations of 0.5g paracetamol contained 0.44g and 0.39g of sodium, respectively, they noted, meaning the maximum daily dose (4g per day) of sodium-containing paracetamol corresponded to 3.5g and 3.1g of sodium, a dose that exceeded World Health Organisation’s recommended total daily allowance of 2g per day.
Commenting on the study findings, Professor Sir Nilesh Samani, medical director at the British Heart Foundation, pointed out that the researchers did not know whether there were any differences in dietary salt consumption between the groups which could have affected the risk of developing a heart and circulatory condition or dying and that the study had looked at people taking sodium-containing paracetamol over an extended period.
‘If you take paracetamol that contains sodium occasionally to manage an isolated headache or very short bouts of pain, these research findings should not cause unnecessary concern,’ he said.
NHS registered dietitian Catherine Collins added that some people were unable to swallow tablets and so needed to take dissolvable medications.
‘For those patients it’s important not to halt their medications simply on these findings, given the authors admit their data is incomplete – daily dietary salt intake wasn’t measured and although death rates were measured, actual cause of death may have related to something entirely irrelevant to their study,’ she said.
However, it was useful to recognise that many popular ‘fizzy’ vitamin supplements contained a significant amount of sodium, which wasn’t always obvious from the front-of-pack labelling.
‘Tablet versions will naturally be low in sodium, so if in doubt, choose these instead,” she said.
Dr Richard Francis, head of research at the Stroke Association, said pill, capsule and oral suspension forms of paracetamol did not usually contain salt, so the findings ‘shouldn’t be too concerning for people using these forms of over-the-counter paracetamol’.
‘People who have been prescribed salty, soluble paracetamol should have its salt content made clearer to them, try to reduce the salt content in the food they eat, work with their doctor to manage their blood pressure and try to switch to a type of paracetamol without salt,’ he said.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.